N4 Ch 30 MedSurg Qs on Blood Probs

1. In a severely anemic patient, the nurse would expect to find
A. dyspnea and tachycardia.
B. cyanosis and pulmonary edema.
C. cardiomegaly and pulmonary fibrosis.
D. ventricular arrhythmias and wheezing.

2. When obtaining assessment data from a patient with a microcytic, normochromic anemia, the nurse would question the patient about
A. folic acid intake.
B. dietary intake of iron.
C. a history of gastric surgery.
D. a history of sickle cell anemia.

3. A nursing intervention for a patient with severe anemia of chronic kidney disease includes
A. monitoring stools for guaiac.
B. instructions in high-iron diet.
C. monitoring urine intake and output.
D. teaching self-injection of erythropoietin.

4. The nursing management of a patient in sickle cell crisis includes
A. bed rest and heparin therapy.
B. blood transfusions and iron replacement.
C. aggressive analgesic and oxygen therapy.
D. platelet administration and monitoring of CBC.

5. A complication of the hyperviscosity of polycythemia is
A. thrombosis.
B. cardiomyopathy.
C. pulmonary edema.
D. disseminated intravascular coagulation (DIC).

6. When providing care for a patient with thrombocytopenia, the nurse must avoid administering aspirin or aspirin-containing products because they
A. interfere with platelet aggregation.
B. may contribute to the destruction of thrombocytes.
C. may mask the fever that occurs with thrombocytopenia.
D. alter blood flow to the homeostatic mechanisms in the brain.

7. The nurse would anticipate that a patient with von Willebrand’s disease undergoing surgery would be treated with administration of vWF and
A. thrombin.
B. factor VI.
C. factor VII.
D. factor VIII.

8. DIC is a disorder in which
A. the coagulation pathway is genetically altered, leading to thrombus formation in all major blood vessels.
B. an underlying disease depletes hemolytic factors in the blood, leading to diffuse thrombotic episodes and infarcts.
C. a disease process stimulates coagulation processes with resultant depletion of clotting factors, leading to diffuse hemorrhage.
D. an inherited predisposition causes a deficiency of clotting factors that leads to overstimulation of coagulation processes in the vasculature.